Fourpath Capital Management’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
Other funds holding SNY
FBT
Fourpath Capital Management's SNY Position: Q3 2026 in Review
Fourpath Capital Management increased its Sanofi (SNY) stake by 6.2% in Q3 2026, buying an estimated $84.6K and bringing the position to 33,438 shares worth $1.38M. The position accounts for 0.18% of the portfolio, ranked #88.
Fourpath Capital Management first reported a position in SNY in Q1 2023 and has held it in 15 quarters since. 112 funds tracked by Wall St. Rank hold SNY as of Q3 2026.
- Fourpath Capital Management held 33,438 shares of Sanofi worth $1.38M as of Q3 2026.
- Fourpath Capital Management bought 1,945 Sanofi shares in Q3 2026, an estimated $84.6K.
- Sanofi made up 0.18% of Fourpath Capital Management's portfolio in Q3 2026, its #88 holding.
- Fourpath Capital Management first reported a position in Sanofi in Q1 2023 and has held it in 15 quarters since.
- 112 funds tracked by Wall St. Rank held Sanofi as of Q3 2026.
Based on Fourpath Capital Management's 13F filing for Q3 2026, filed 19 Oct 2026.